<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:50:50Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8516890" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8516890</identifier>
        <datestamp>2021-10-29</datestamp>
        <setSpec>npjmicrogr</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">NPJ Microgravity</journal-id>
              <journal-id journal-id-type="iso-abbrev">NPJ Microgravity</journal-id>
              <journal-title-group>
                <journal-title>NPJ Microgravity</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2373-8065</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8516890</article-id>
              <article-id pub-id-type="pmcid">PMC8516890</article-id>
              <article-id pub-id-type="pmc-uid">8516890</article-id>
              <article-id pub-id-type="pmid">34650071</article-id>
              <article-id pub-id-type="publisher-id">165</article-id>
              <article-id pub-id-type="doi">10.1038/s41526-021-00165-5</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Opposite response of blood vessels in the retina to 6° head-down tilt and long-duration microgravity</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Taibbi</surname>
                    <given-names>Giovanni</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Young</surname>
                    <given-names>Millennia</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vyas</surname>
                    <given-names>Ruchi J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Murray</surname>
                    <given-names>Matthew C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lim</surname>
                    <given-names>Shiyin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Predovic</surname>
                    <given-names>Marina</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jacobs</surname>
                    <given-names>Nicole M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Askin</surname>
                    <given-names>Kayleigh N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mason</surname>
                    <given-names>Sara S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zanello</surname>
                    <given-names>Susana B.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vizzeri</surname>
                    <given-names>Gianmarco</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Theriot</surname>
                    <given-names>Corey A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Parsons-Wingerter</surname>
                    <given-names>Patricia</given-names>
                  </name>
                  <address>
                    <email>patriciaparsonsw@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.176731.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1547 9964</institution-id><institution>Department of Ophthalmology and Visual Sciences, </institution><institution>The University of Texas Medical Branch at Galveston, </institution></institution-wrap>Galveston, TX USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.419085.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0613 2864</institution-id><institution>NASA Johnson Space Center, </institution></institution-wrap>Houston, TX USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.419075.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 1955 7990</institution-id><institution>Mori Associates, Ames Research Center, NASA, Moffett Field, </institution></institution-wrap>Mountain View, CA USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.419075.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 1955 7990</institution-id><institution>Blue Marble Space Institute of Science, Space Biology Division, Space Technology Mission Directorate, Ames Research Center, NASA, Moffett Field, </institution></institution-wrap>Mountain View, CA USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.419075.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 1955 7990</institution-id><institution>National Space Biomedical Research Institute, Ames Research Center, NASA, Moffett Field, </institution></institution-wrap>Mountain View, CA USA </aff>
                <aff id="Aff6"><label>6</label>Aegis Aerospace, Inc. Houston, Houston, TX USA </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.419085.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0613 2864</institution-id><institution>KBR, NASA Johnson Space Center, </institution></institution-wrap>Houston, TX USA </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.176731.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1547 9964</institution-id><institution>Department of Preventive Medicine and Community Health, The University of Texas Medical Branch, </institution></institution-wrap>Galveston, TX USA </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.419077.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0637 6607</institution-id><institution>Low Gravity Exploration Technology, Research and Engineering Directorate, John Glenn Research Center, NASA, </institution></institution-wrap>Cleveland, OH USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>14</day>
                <month>10</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>14</day>
                <month>10</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>7</volume>
              <elocation-id>38</elocation-id>
              <history>
                <date date-type="received">
                  <day>18</day>
                  <month>12</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>19</day>
                  <month>8</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">The Spaceflight Associated Neuro-ocular Syndrome (SANS), associated with the headward fluid shifts incurred in microgravity during long-duration missions, remains a high-priority health and performance risk for human space exploration. To help characterize the pathophysiology of SANS, NASA’s VESsel GENeration Analysis (VESGEN) software was used to map and quantify vascular adaptations in the retina before and after 70 days of bed rest at 6-degree Head-Down Tilt (HDT), a well-studied microgravity analog. Results were compared to the retinal vascular response of astronauts following 6-month missions to the International Space Station (ISS). By mixed effects modeling, the trends of vascular response were opposite. Vascular density decreased significantly in the 16 retinas of eight astronauts and in contrast, increased slightly in the ten retinas of five subjects after HDT (although with limited significance). The one astronaut retina diagnosed with SANS displayed the greatest vascular loss. Results suggest that microgravity is a major variable in the retinal mediation of fluid shifts that is not reproduced in this HDT bed rest model.</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Preclinical research</kwd>
                <kwd>Physiology</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000104</institution-id>
                      <institution>National Aeronautics and Space Administration (NASA)</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <award-id>NNJ12ZSA002N</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Taibbi</surname>
                      <given-names>Giovanni</given-names>
                    </name>
                    <name>
                      <surname>Vyas</surname>
                      <given-names>Ruchi J.</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>Matthew C.</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>Shiyin</given-names>
                    </name>
                    <name>
                      <surname>Predovic</surname>
                      <given-names>Marina</given-names>
                    </name>
                    <name>
                      <surname>Jacobs</surname>
                      <given-names>Nicole M.</given-names>
                    </name>
                    <name>
                      <surname>Askin</surname>
                      <given-names>Kayleigh N.</given-names>
                    </name>
                    <name>
                      <surname>Mason</surname>
                      <given-names>Sara S.</given-names>
                    </name>
                    <name>
                      <surname>Zanello</surname>
                      <given-names>Susana B.</given-names>
                    </name>
                    <name>
                      <surname>Vizzeri</surname>
                      <given-names>Gianmarco</given-names>
                    </name>
                    <name>
                      <surname>Theriot</surname>
                      <given-names>Corey A.</given-names>
                    </name>
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>Patricia</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100006203</institution-id>
                      <institution>NASA | Johnson Space Center (JSC)</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NNJ12ZSA002N</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Young</surname>
                      <given-names>Millennia</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par2">Recent NASA studies have established that serious risks for ocular/visual impairments are associated with microgravity exposure on the International Space Station (ISS), especially during long-duration missions<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR9">9</xref></sup>. Designated the Spaceflight Associated Neuro-ocular Syndrome (SANS, formerly Vision Impairment &amp; Intracranial Pressure (VIIP) syndrome), ocular changes include optic disc edema (ODE), increased retinal and choroidal thicknesses, posterior globe flattening with hyperopic shift, choroidal flattening and folds, cotton wool spots, and decreased near visual acuity (hyperopic shift)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Although the clinical incidence of SANS for these missions is approximately 15%, a subclinical incidence by ODE is estimated to occur in the majority of astronauts after missions of six months or longer<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>.</p>
              <p id="Par3">For this study, we tested the hypothesis that the headward fluid shifts associated with SANS and Head-Down-Tilt (HDT) bed rest, a well-established microgravity analog, are mediated at least in part by retinal blood vessels. The hypothesis further predicts that retinal vascular response occurs primarily in the more actively remodeling and fragile small vessels, as was observed previously for diabetic retinopathy and for microvascular response in other tissues to various pathological and physiological factors<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR25">25</xref></sup>. A well-established role of the microvasculature throughout the body is the regulation and maintenance of the intravascular and extravascular fluid balances within all tissues and organs, including the highly vascularized retina<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. By this view, the microvascular endothelia and associated smooth muscle and pericytes are not only responders—but also active players and mediators—of fluid balances within a tissue.</p>
              <p id="Par4">Specifically for the study, vascular response in the retinas of healthy subjects undergoing 70 days of 6° HDT bed rest, an established ground-based spaceflight analog<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>, was compared to that of long-duration ISS crew members. The study protocol was essentially identical to that used previously for progression of diabetic retinopathy<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. Arterial and venous patterns extracted from conventional ophthalmic images of the retina were mapped and quantified by several vascular parameters using the VESsel GENeration Analysis (VESGEN) software that was globally released by NASA in 2019<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. The original VESGEN analysis was motivated by experimental observations in rodent and avian models that major molecular regulators such as VEGF and FGF induce unique ‘fingerprint’ or ‘signature’ vascular patterns within functionally diverse generations of fractally branching vascular trees<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. The software quantification was therefore developed as a suite of complementary vascular parameters to characterize the fractal-based complexity of numerous uniquely branching vascular patterns. Parameters analyzed by VESGEN for the diabetic and current SANS retinal studies include the fractal dimension (<italic>D</italic><sub>f</sub>), a sensitive estimator of vascular space-filling capacity, and vessel length density (<italic>L</italic><sub>v</sub>) as a confirming measure<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. To determine whether the small vessels were the primary responders, as was found for previous studies, the vascular results were further grouped by the software into branching generations of large (<italic>G</italic><sub>v1-4</sub>) and small vessels of generations five or smaller (<italic>G</italic><sub>v≥5</sub>). Results by VESGEN for the selective remodeling by small vessels in early diabetic retinopathy, the major blinding disease of working-aged adults, introduced new insights on disease progression that are encouraging for the development of early-stage regenerative therapies when progression may still be reversible<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. A similar approach to early-stage monitoring by VESGEN of SANS progression could support countermeasure strategies for early-stage reversibility.</p>
              <p id="Par5">A fractal dimension is of fractional value, unlike the integers that specify the lines, planes, and solids of Euclidean geometry. Developed by B. Mandelbrot and others<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>, fractal mathematics describes complex space-filling patterns that include vascular and neuronal branching, coastlines, trees, and the species-specific vascular patterning of angiosperm leaves such as oak and maple<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Fractals often display the property of self similarity (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), by which a characteristic pattern such as vascular bifurcational (dichotomous) branching is repeated at decreasing length scales. For a binary (black/white) vascular pattern in a 2D image, <italic>D</italic><sub>f</sub> is a fractional value lying between 1 and 2 that increases with vascular density. In previous human and other studies<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, <italic>D</italic><sub>f</sub> ranged in skeletonized (linearized) vascular images from approximately 1.20–1.48, and often from 1.25–1.40. The skeletonized vascular representation, particularly of the more sparse vascular patterns used for this study, was found to be highly sensitive to physiological changes in vascular space-filling capacity<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.<fig id="Fig1"><label>Fig. 1</label><caption><title>Self-similarity of fractally bifurcating patterns in branching vascular trees.</title><p><bold>a</bold> The fundamental pattern of self-similar bifurcational branching in vascular systems is illustrated by the schematic for successive ‘offspring’ generations (<italic>G</italic><sub>2</sub>–<italic>G</italic><sub>7</sub>) that branch from a single parent vessel (<italic>G</italic><sub>1</sub>). The pattern displays iterative self-similarity at decreasing length scales<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. The repeated pattern within the circle demonstrates how vessels can continue to branch below the level of image resolution. This phenomenon is a key feature of results reported here and elsewhere<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup> for both ISS crew members and HDT subjects, in which many small vessels were not detected due to limiting resolution of the Heidelberg Spectralis infrared (IR) ophthalmic imaging. <bold>b</bold> The VESGEN software assigned the vessels to seven generations of vascular branching and calculated the fractal dimension (<italic>D</italic><sub>f</sub>) of the binary (red/white) pattern and its detail as 1.55 and 1.54, respectively (<italic>D</italic><sub>f</sub> of skeletonized images, 1.17 and 1.18). For a mathematically symmetric vascular fractal subject to the bifurcational branching rule <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathop {\sum}\nolimits_{n = 0}^5 {} 2^n$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:msubsup><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msubsup><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41526_2021_165_Article_IEq1.gif"/></alternatives></inline-formula> = 2<sup>0</sup> + 2<sup>1</sup> + 2<sup>2</sup> + 2<sup>3</sup> + 2<sup>4</sup> + 25 = 63, the parent blood vessel would generate 32 small vessels in the sixth generation, <italic>G</italic><sub>6</sub> (<italic>G</italic><sub>1</sub>–<italic>G</italic><sub>6</sub>, 63 vessels total) for self-similar branching of decreasing vessel length. However, the vascular schematic depicts a more realistic biological fractal that is somewhat asymmetric. For this generalized example, iterative rules for vessel length and branching angle are not specified. In realistic human and vertebrate vascular branching, the bifurcational branching pattern is supplemented by the addition of many small ‘offshoot’ vessels to adequately vascularize the tissue (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).</p></caption><graphic xlink:href="41526_2021_165_Fig1_HTML" id="d32e741"/></fig></p>
              <p id="Par6">Reported in greater detail elsewhere<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, the overall density of arteries and veins by <italic>D</italic><sub>f</sub> and <italic>L</italic><sub>v</sub> decreased significantly in the retinas of ISS crew members after six-month missions, especially that of small vessels. However, vascular decreases were highly variable among individual retinas. Decreases ranged from none or low up to 76% of the greatest loss in a retina diagnosed clinically with SANS by measures that include optic disc edema (ODE) and choroidal folds. A Subclinical Vascular Pathology Index (SVPI) was therefore established by comparing the vascular changes in the SANS retina to those of the other retinas. The results for ISS crew members are consistent with the highly variable clinical and subclinical incidence estimated for SANS by previously established measures such as ODE and peripapillary choroidal thickness<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR9">9</xref></sup>. The purpose of this report is to compare the retinal vascular response to 70 days of HDT with that of long-duration microgravity.</p>
            </sec>
            <sec id="Sec2" sec-type="results">
              <title>Results</title>
              <sec id="Sec3">
                <title>Comparison of ISS and HDT vascular response</title>
                <p id="Par7">Changes in the arterial and venous patterning of ten retinas in five healthy subjects before and after 70 days of HDT bed rest at NASA’s Flight Analogs Research Unit (FARU)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> and of 16 retinas in eight U.S. crew members before and after 6-month missions to the ISS were mapped and quantified. The 35° Spectralis IR imaging conditions for the HDT and ISS cohorts were highly similar, and include performing the eye exam and imaging in the standard seated position post-HDT and post-ISS (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>). The comparison of vascular patterns within images focused on the macular region in the HDT and on the optic disc in astronauts was not ideal but was limited by the availability of relevant image sets. Nonetheless, the macular region is almost completely captured by the field of view (FOV) in both image sets. Importantly, given the relatively low level of Spectralis IR resolution, the lack of vessels in the foveal avascular zone appears similar in both the HDT and ISS FOV (Figs. <xref rid="Fig2" ref-type="fig">2</xref>–<xref rid="Fig4" ref-type="fig">4</xref>), where the smallest vessels are not captured by either imaging. Overall, comparison of the HDT and ISS vascular image sets was judged to be reasonable because magnification and imaging modality are essentially equivalent. In addition, the image sets were acquired in follow-up mode, resulting in alignment across test sessions within individuals.<fig id="Fig2"><label>Fig. 2</label><caption><title>Mapping and quantification by VESGEN of retinal vascular patterning before and after HDT.</title><p><bold>a</bold> From the grayscale Spectralis IR image of the right retina of subject 2 acquired before 70 days of HDT (Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>), binary images of the <bold>b</bold> arterial and <bold>c</bold> venous trees were extracted to serve as the sole image inputs to VESGEN. <bold>d</bold> The same procedure was followed for the image acquired after 70 days of HDT. <bold>e</bold>, <bold>i</bold> The skeleton (centerline) of the pre-HDT arterial or venous tree was calculated by VESGEN that, together with the input binary image, generated additional maps of arterial and venous branching generations (<bold>f</bold>, <bold>j</bold>, legend). These generational maps were further grouped by the software into large (<italic>L</italic><sub>v1-4</sub>, red) and small (<italic>L</italic><sub>v≥5</sub>, yellow) vessels (<bold>g</bold>, <bold>k</bold>) for calculation of the final grouped vascular results (Table <xref rid="Tab2" ref-type="table">2</xref>, Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>)<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. The same analysis was followed for the post-HDT image (<bold>d</bold>, illustrated in <bold>h</bold> and <bold>l</bold>). Scale bars (<bold>a</bold>, <bold>d</bold>), 200 μm.</p></caption><graphic xlink:href="41526_2021_165_Fig2_HTML" id="d32e869"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><title>Representative increases in vascular density before and after 70 days of HDT.</title><p>For the right and left retinas of subject 4 (Table <xref rid="Tab2" ref-type="table">2</xref>; Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>), vascular density increased slightly according to mean values except for the left arterial density that remained essentially unchanged. As illustrated in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, binary arterial and venous trees from grayscale retinal images (<bold>a</bold>–<bold>d</bold>) were analyzed by VESGEN as vascular skeletons (<bold>e</bold>–<bold>h</bold>, <bold>m</bold>–<bold>p</bold>) and branching trees grouped into large (<italic>G</italic><sub>v1-4</sub>, red) and small (<italic>G</italic><sub>v5-6</sub>, yellow) generations (<bold>i</bold>–<bold>l</bold>, <bold>q</bold>–<bold>t</bold>). Right arterial and venous length densities (<italic>L</italic><sub>v</sub>) before HDT, 13.34 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 13.37 × 10<sup>–4</sup> μm/μm<sup>2</sup>; after, 13.97 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 15.17 × 10<sup>–4</sup> μm/μm<sup>2</sup>. Left arterial and venous length densities (<italic>L</italic><sub>v</sub>) before HDT, 16.07 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 15.07 × 10<sup>–4</sup> μm/μm<sup>2</sup>; after, 16.00 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 16.04 × 10<sup>–4</sup> μm/μm<sup>2</sup>. Scale bars (<bold>a</bold>–<bold>d</bold>), 200 μm.</p></caption><graphic xlink:href="41526_2021_165_Fig3_HTML" id="d32e999"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><title>Representative vascular decreases in the retinas of an astronaut after 6 months in microgravity.</title><p>Compared to a scale of 100% established by retinal arterio-venous loss in a crew member diagnosed with SANS<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, arterial and venous density decreased in post-flight right and left retinas of this crew member by 35% and 8%, respectively. As for HDT subjects (Fig. <xref rid="Fig3" ref-type="fig">3</xref>), vascular trees extracted from grayscale images (<bold>a</bold>–<bold>d</bold>) were analyzed by VESGEN as skeletons (<bold>e</bold>–<bold>h</bold>, <bold>m</bold>–<bold>p</bold>) and branching trees grouped into large (<italic>G</italic><sub>v1-4</sub>, red) and small (<italic>G</italic><sub>v5-6</sub>, yellow) generations (<bold>i</bold>–<bold>l</bold>, <bold>q</bold>–<bold>t</bold>). Pre- to post-flight arterial and venous results for <italic>D</italic><sub>f</sub> in right retina, 1.38 to 1.35 and 1.36 to 1.35, respectively; for <italic>L</italic><sub>v</sub>, 14.4 to 12.6 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 13.0 to 12.4 × 10<sup>–4</sup> μm/μm<sup>2</sup>. Similarly for left retina, 1.35 to 1.35 and 1.34 to 1.33; 12.4 to 12.6 × 10<sup>–</sup><sup>4</sup> μm/μm<sup>2</sup> and 11.6 to 11.1 × 10<sup>–4</sup> μm/μm<sup>2</sup>. For astronauts, Spectralis IR imaging was centered on the optic disc, not on the macula as for HDT subjects. Scale bars (<bold>a</bold>–<bold>d</bold>), 200 μm.</p></caption><graphic xlink:href="41526_2021_165_Fig4_HTML" id="d32e1105"/></fig></p>
                <p id="Par8">The opposite patterns of vascular response by <italic>D</italic><sub>f</sub>, <italic>L</italic><sub>v</sub>, and <italic>L</italic><sub>v≥5</sub> in the HDT and astronaut retinas were compared by mixed models (Table <xref rid="Tab1" ref-type="table">1</xref>). While crewmembers experienced pre- to post-mission vascular decreases, HDT subjects displayed slight increases in the same parameters before and after bedrest. As hypothesized, these differences in vascular response resulted primarily from changes in the small vessels as measured by vessel length density (<italic>L</italic><sub>v≥5</sub>). The pre-to-post density of larger arteries and veins (<italic>L</italic><sub>v1-4</sub>) did not differ meaningfully between the HDT and ISS cohorts.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Comparison of change in arterial and venous density in retinas of 6° HDT subjects and ISS crew members.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Vascular tree</th><th>Parameter</th><th>Symbol</th><th>F-test time*group df 3 and 37[value (<italic>p</italic>-value)]<sup>a</sup></th><th>Crew pre to post change, mean ± SE</th><th>HDT pre to post change, mean ± SE</th><th><italic>P</italic> value for comparison of changes</th></tr></thead><tbody><tr><td rowspan="4">Arterial</td><td>Fractal dimension</td><td><italic>D</italic><sub>f</sub></td><td>3.50 (0.0248)</td><td>−0.016 ± 0.007<sup>b</sup></td><td>+0.017±0.008</td><td>0.0027</td></tr><tr><td>Length density <italic>All vessels</italic></td><td><italic>L</italic><sub>v</sub></td><td>10.32 (&lt;0.0001)</td><td>−8.2E-5 ± 3.7E-5<sup>b</sup></td><td>+5E-5 ± 3.9E-5</td><td>0.0215</td></tr><tr><td><italic>Large vessels</italic></td><td><italic>L</italic><sub>v1–4</sub></td><td>0.22 (0.8790)</td><td>+1E-5 ± 1.8E-5<sup>b</sup></td><td>+7.73E-6 ± 1.8E-5</td><td>0.9056</td></tr><tr><td><italic>Small vessels</italic></td><td><italic>L</italic><sub>v≥5</sub></td><td>15.46 (&lt;0.0001)</td><td>−9.2E-5 ± 3E-5<sup>b</sup></td><td>+4E-5 ± 2.5E-4</td><td>0.0020</td></tr><tr><td rowspan="4">Venous</td><td>Fractal dimension</td><td><italic>D</italic><sub>f</sub></td><td>3.85 (0.0170)</td><td>−0.015 ± 0.005<sup>b</sup></td><td>+0.017 ± 0.009</td><td>0.0035</td></tr><tr><td>Length density <italic>All vessels</italic></td><td><italic>L</italic><sub>v</sub></td><td>17.83 (&lt;0.0001)</td><td>−6.5E-5 ± 2.9E-5<sup>b</sup></td><td>+6E-5 ± 2.9E-5</td><td>0.0107</td></tr><tr><td><italic>Large vessels</italic></td><td><italic>L</italic><sub>v1–4</sub></td><td>2.09 (0.1181)</td><td>+1E-5 ± 9.3E-6<sup>b</sup></td><td>+2E-5 ± 1.5E-5</td><td>0.5555</td></tr><tr><td><italic>Small vessels</italic></td><td><italic>L</italic><sub>v≥5</sub></td><td>11.72 (0.0001)</td><td>−7.5E-5 ± 3.1E-5<sup>b</sup></td><td>+4E-5 ± 4E-5</td><td>0.0252</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Differences in vascular parameters generated by VESGEN for 10 retinas of five subjects before and after 70 days of HDT bed rest compared to 16 retinas of eight ISS crew members before and after 6-month missions to the ISS were estimated using expected marginal means of mixed-effects models, where df denotes degrees of freedom for F distributions.</p><p><sup>b</sup>Results reproduced from study of retinal vascular loss in ISS crew members with and without SANS<sup><xref ref-type="bibr" rid="CR25">25</xref></sup><italic>D</italic><sub>f</sub>, fractal dimension (dimensionless), <italic>L</italic><sub>v</sub> overall vessel length density, <italic>L</italic><sub>v1-4</sub> vessel length density of generations one to four, <italic>L</italic><sub>v≥5</sub> vessel length density of generations ≥5. By study hypothesis, vascular response was predicted primarily for small (<italic>L</italic><sub>v≥5</sub>) but not large (<italic>L</italic><sub>v</sub><sub>1-4</sub>) vessels.</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec4">
                <title>Detailed analysis of HDT vascular response</title>
                <p id="Par9">Trends of increased density in post-HDT retinal vessels detected by the sensitive VESGEN analysis were modest (Table <xref rid="Tab2" ref-type="table">2</xref>; individual fractal results in Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>). Arterio-venous densities increased in 50% of the HDT retinas by a cutoff value of Δ<italic>D</italic><sub>f</sub> &gt; |0.02 | (Table <xref rid="Tab2" ref-type="table">2</xref>). This value was derived from previous studies<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup> as indicative of significant change in vascular space-filling capacity. By the Δ<italic>D</italic><sub>f</sub> cutoff, no vascular decreases were found. Transitional increases in <italic>D</italic><sub>f</sub> were measured for two retinas and a transitional decrease, for only one retina. Results for HDT are illustrated by modest increases in retinal arterial and venous densities of three retinas that are consistent with mean changes in the population (Figs. <xref rid="Fig2" ref-type="fig">2</xref>–<xref rid="Fig3" ref-type="fig">3</xref>; Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>). Overall arterial and venous length densities (<italic>L</italic><sub>v</sub>) in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, for example, were quantified as 14.88 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 14.10 × 10<sup>–4</sup> μm/μm<sup>2</sup> before HDT, compared to 15.91 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 16.03 × 10<sup>–4</sup> μm/μm<sup>2</sup> after HDT. Varying values in <italic>D</italic><sub>f</sub>, <italic>L</italic><sub>v1-4</sub>, and <italic>L</italic><sub>v&gt;5</sub> before and after HDT for each of the 10 de-identified retinas are further illustrated (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). No significant changes in vessel diameter and tortuosity were measured for the HDT and ISS retinas, although subtle changes in these vascular characteristics may not have been captured by the relatively low Spectralis IR imaging.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Change of arterial and venous density in retinas of 6° HDT subjects after 70 days of bed rest.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Vascular tree</th><th>Symbol</th><th>HDT time</th><th>Results, Mean ± SE</th><th>Pre-to-post change, Mean ± SE</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="4">Arterial</td><td><italic>D</italic><sub>f</sub></td><td><p>Pre</p><p>Post</p></td><td><p>1.334 ± 0.012</p><p>1.351 ± 0.011</p></td><td>+0.017 ± 0.008</td><td>0.031</td></tr><tr><td><italic>L</italic><sub>v</sub></td><td><p>Pre</p><p>Post</p></td><td><p>1.39E-3 ± 7.0E-5</p><p>1.44E-3 ± 4.9E-5</p></td><td>+5E-5 ± 3.9E-5</td><td>0.233</td></tr><tr><td><italic>L</italic><sub>v1–4</sub></td><td><p>Pre</p><p>Post</p></td><td><p>7.71E-4 ± 2.3E-5</p><p>7.79E-4 ± 2.9E-5</p></td><td>+7.76E-6 ± 1.8E-5</td><td>0.677</td></tr><tr><td><italic>L</italic><sub>v≥5</sub></td><td><p>Pre</p><p>Post</p></td><td><p>6.24E-4 ± 6E-5</p><p>6.63E-4 ± 4.5E-5</p></td><td>+4E-5 ± 2.5E-5</td><td>0.122</td></tr><tr><td rowspan="4">Venous</td><td><italic>D</italic><sub>f</sub></td><td><p>Pre</p><p>Post</p></td><td><p>1.338 ± 0.011</p><p>1.355 ± 0.010</p></td><td>+0.017 ± 0.009</td><td>0.058</td></tr><tr><td><italic>L</italic><sub>v</sub></td><td><p>Pre</p><p>Post</p></td><td><p>1.49E-3 ± 7.5E-5</p><p>1.56E-3 ± 6.0E-5</p></td><td>+6.0 ± 3.8E-5</td><td>0.100</td></tr><tr><td><italic>L</italic><sub>v1–4</sub></td><td><p>Pre</p><p>Postt</p></td><td><p>6.66E-3 ± 3.4E-5</p><p>6.88E-3 ± 3.7E-5</p></td><td>+2E-5 ± 1.5E-5</td><td>0.153</td></tr><tr><td><italic>L</italic><sub>v≥5</sub></td><td><p>Pre</p><p>Pos</p></td><td><p>8.27E-4 ± 4.7E-5</p><p>8.69E-4 ± 4.1E-5</p></td><td>+4E-5 ± 4E-5</td><td>0.230</td></tr></tbody></table><table-wrap-foot><p>HDT-related changes were estimated for HDT subjects (<italic>n</italic> = 5, 10 retinas) using expected marginal means from mixed models. <italic>D</italic><sub>f</sub>, fractal dimension (dimensionless), <italic>L</italic><sub>v</sub> overall vessel length density, <italic>L</italic><sub>v1-4</sub> vessel length density of generations one to four, <italic>L</italic><sub>v≥5</sub> vessel length density of generations ≥5. By study hypothesis, vascular response was predicted primarily for small (<italic>L</italic><sub>v≥5</sub>) but not large (<italic>L</italic><sub>v1-4</sub>).</p></table-wrap-foot></table-wrap><fig id="Fig5"><label>Fig. 5</label><caption><title>Variability in vascular response of individual HDT subjects after 70 days of bed rest.</title><p>Comparison of values of vascular parameters <italic>D</italic><sub>f</sub>, <italic>L</italic><sub>v1-4</sub>, and <italic>L</italic><sub>v&gt;5</sub> for each of the 10 de-identified retinas, and their pre-post change, before and after HDT. The two retinas of an individual subject are denoted by the same color. As hypothesized, the larger vessels (<italic>L</italic><sub>v1-4</sub>) did not remodel as greatly as the smaller vessels (<italic>L</italic><sub>v&gt;5</sub>). The variability of retinal vascular response is consistent with the variability measured for other ocular changes in both astronaut and HDT populations such as ODE and retinal and choroidal thickness. In the <italic>L</italic><sub>v1-4</sub> column for veins, lower blue and orange bars overlap with green bar.</p></caption><graphic xlink:href="41526_2021_165_Fig5_HTML" id="d32e1859"/></fig></p>
              </sec>
              <sec id="Sec5">
                <title>Establishing Subclinical Vascular Pathology Index (SVPI) from SANS incidence</title>
                <p id="Par10">Importantly as detailed elsewhere<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, the retina of one crew member displaying the largest vascular decreases was also the only retina diagnosed post-flight with SANS by established clinical measures such as ODE and choroidal folds. Globe flattening, ODE and increases in refractive error total retinal thickness (TRT) were greatest in this SANS retina. No changes in visual acuity were reported by any crew member<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. No statistically significant association between intraocular pressure (IOP) and VESGEN parameters were found. From this retina, the SVPI was established to quantify relative decreases in vascular density of the other 15 retinas. By the SVPI, three other retinas displayed significant vascular decreases from 67 to 76% of vascular loss in the SANS retina<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. To illustrate the mean values of modest vascular decrease in most of the ISS cohort (Fig. <xref rid="Fig4" ref-type="fig">4</xref>)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, pre- to post-flight arterial and venous changes by <italic>D</italic><sub>f</sub> in the right retina of this crew member were 1.38 to 1.35 and 1.36 to 1.35, respectively; by <italic>L</italic><sub>v</sub>, 44.55 to 39.11 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 40.13 to 38.34 × 10<sup>–4</sup> μm/μm<sup>2</sup>. For the left retina, pre- to post-flight arterial and venous values for <italic>D</italic><sub>f</sub> were 1.35 to 1.35 (no change) and 1.34 to 1.33; for <italic>L</italic><sub>v</sub>, 38.29 to 39.00 × 10<sup>–4</sup> μm/μm<sup>2</sup> and 36.69 to 34.50 × 10<sup>–4</sup> μm/μm<sup>2</sup>. For a recent publication by Laurie et al.<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, the earliest signs of optic disc edema were determined to be a change in TRT (0–250 µm) greater than 19.7 µm. Based on this definition of optic disc edema currently accepted by NASA<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, 60% of the crew members in the current study displayed one or more signs of SANS (3/5 crew members; TRT data were not available for 3 crew members).</p>
              </sec>
              <sec id="Sec6">
                <title>Association between VESGEN results for HDT with other ophthalmic measures</title>
                <p id="Par11">Mixed-effects models were used to evaluate the association between the VESGEN vascular results and ophthalmic measures in the HDT cohort that include LogMAR visual acuity, spherical equivalent, IOP, Spectralis OCT retinal nerve fiber layer thickness, and peripapillary and macular total retinal thicknesses (Table <xref rid="Tab3" ref-type="table">3</xref>). Given the small sample size (<italic>n</italic> = 5, 10 retinas) and large number of ophthalmic measures of interest, this evaluation can only be considered an exploratory analysis to identify possible associations for further study. Unadjusted <italic>p</italic>-values are reported alongside false discovery rates (FDR) to put the multiple testing conducted around these measures in context. Small, subclinical increases in peripapillary retinal thickness were reported previously after 70-day HDT bed rest<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Association of ocular measures and arterial and venous density in retinas of 6° HDT subjects after 70 days of bed rest.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Symbol</th><th rowspan="2">Ocular measure</th><th colspan="3">Arterial</th><th colspan="3">Venous</th></tr><tr><th>Results, Coeff ± SE</th><th><italic>P</italic> value</th><th>FDR</th><th>Results, Coeff ± SE</th><th><italic>P</italic> value</th><th>FDR</th></tr></thead><tbody><tr><td rowspan="7"><italic>D</italic><sub>f</sub></td><td>RNFL thickness</td><td>−9E-5 ± 6.8E-4</td><td>0.90</td><td>0.97</td><td>−2.3E-4 ± 1.0E-3</td><td>0.83</td><td>0.91</td></tr><tr><td>Peripapillary thickness</td><td>1.0E-3 ± 2.9E-4</td><td>0.01</td><td>0.06</td><td>2.7E-6 ± 3.4E-4</td><td>0.99</td><td>0.99</td></tr><tr><td>Macular thickness</td><td>1.1E-3 ± 1.5E-3</td><td>0.49</td><td>0.74</td><td>3.5E-4 ± 5.5E-4</td><td>0.55</td><td>0.74</td></tr><tr><td>IOP</td><td>6.2E-4 ± 1.8E-3</td><td>0.74</td><td>0.84</td><td>3.5E-3 ± 1.1E-3</td><td>0.02</td><td>0.09</td></tr><tr><td>Spherical equivalent refraction</td><td>−1.1E-2 ± 1.9E-2</td><td>0.58</td><td>0.74</td><td>9.7E-3 ± 3.3E-3</td><td>0.02</td><td>0.09</td></tr><tr><td>Near LogMAR</td><td>0.186 ± 0.155</td><td>0.26</td><td>0.55</td><td>0.070 ± 0.090</td><td>0.48</td><td>0.74</td></tr><tr><td>Distance LogMAR</td><td>0.397 ± 0.072</td><td>0.00</td><td>0.02</td><td>0.107 ± 0.028</td><td>0.00</td><td>0.06</td></tr><tr><td rowspan="7"><italic>L</italic><sub>v1–4</sub></td><td>RNFL thickness</td><td>3.6E-6 ± 2.0E-6</td><td>0.11</td><td>0.32</td><td>2.7E-6 ± 2.0E-6</td><td>0.21</td><td>0.52</td></tr><tr><td>Peripapillary thickness</td><td>1.2E-6 ± 1.2E-6</td><td>0.34</td><td>0.65</td><td>9.6E-7 ± 1.3E-6</td><td>0.48</td><td>0.74</td></tr><tr><td>Macular thickness</td><td>2.1E-6 ± 1.6E-6</td><td>0.25</td><td>0.54</td><td>1.3E-6 ± 2.1E-6</td><td>0.55</td><td>0.74</td></tr><tr><td>IOP</td><td>−2.1E-6 ± 3.5E-6</td><td>0.57</td><td>0.74</td><td>−2.1E-6 ± 4.8E-6</td><td>0.67</td><td>0.80</td></tr><tr><td>Spherical equivalent refraction</td><td>−1.6E-6 ± 1.7E-5</td><td>0.93</td><td>0.97</td><td>−2E-5 ± 3.1E-5</td><td>0.54</td><td>0.74</td></tr><tr><td>Near LogMAR</td><td>3.3E-4 ± 1.1E-4</td><td>0.02</td><td>0.09</td><td>−6E-5 ± 1.3E-4</td><td>0.65</td><td>0.80</td></tr><tr><td>Distance LogMAR</td><td>1.9E-4 ± 1.7E-4</td><td>0.32</td><td>0.64</td><td>−3.5E-4 ± 2.3E-4</td><td>0.17</td><td>0.44</td></tr><tr><td rowspan="7"><italic>L</italic><sub>v≥5</sub></td><td>RNFL thickness</td><td>8.8E-6 ± 4.1E-6</td><td>0.51</td><td>0.74</td><td>5.3E-6 ± 2.9E-6</td><td>0.10</td><td>0.32</td></tr><tr><td>Peripapillary thickness</td><td>3.0E-6 ± 0</td><td>0.02</td><td>0.09</td><td>3.0E-6 ± 0</td><td>0.00</td><td>0.06</td></tr><tr><td>Macular thickness</td><td>2.8E-6 ± 4.8E-6</td><td>0.58</td><td>0.74</td><td>2.0E-6 ± 5.5E-6</td><td>0.73</td><td>0.84</td></tr><tr><td>IOP</td><td>4.9E-6 ± 6.7E-6</td><td>0.49</td><td>0.74</td><td>1.6E-5 ± 1.2E-5</td><td>0.23</td><td>0.53</td></tr><tr><td>Spherical equivalent refraction</td><td>−2.8E-6 ± 1.0E-4</td><td>0.98</td><td>0.99</td><td>9.9E-5 ± 5.2E-5</td><td>0.09</td><td>0.32</td></tr><tr><td>Near LogMAR</td><td>−1.3E-3 ± 4.3E-4</td><td>0.02</td><td>0.09</td><td>−8.4E-4 ± 4.8E-4</td><td>0.12</td><td>0.34</td></tr><tr><td>Distance LogMAR</td><td>1.2E-3 ± 5.9E-4</td><td>0.08</td><td>0.30</td><td>9.4E-4 ± 2.7E-4</td><td>0.01</td><td>0.06</td></tr></tbody></table><table-wrap-foot><p>Comparison of ocular measures and vascular parameters generated by VESGEN for 10 retinas of five subjects who underwent 70 days of HDT bed rest. <italic>D</italic><sub>f</sub> fractal dimension (dimensionless). <italic>L</italic><sub>v</sub> overall vessel length density, <italic>L</italic><sub>v1-4</sub> vessel length density of generations one to four, <italic>L</italic><sub>v≥5</sub> vessel length density of generations ≥5. FDR false discovery rate.</p></table-wrap-foot></table-wrap></p>
              </sec>
            </sec>
            <sec id="Sec7" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par12">Trends for microvascular response within the retina were found by VESGEN to be opposite for 70 days of 6° HDT bed rest and six months of microgravity on the ISS. By several confirming measures of small and overall vessel density, vascular patterning increased slightly with HDT and decreased significantly in astronauts. Subtle vascular changes or differences that are not apparent by visual inspection of the clinical grayscale images were quantified. Retinal vascular adaptations in the two healthy, relatively young populations were generally modest, compared to much greater vascular changes in potentially blinding vascular-dependent pathologies such as diabetic retinopathy<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> or age-related macular degeneration<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> that typically develop over years.</p>
              <p id="Par13">Results for subtle vascular change by the sensitive VESGEN analysis provide preliminary confirmation of our hypothesis that the retinal microvasculature necessarily remodels to accommodate the headward fluid shifts incurred during microgravity and HDT and furthermore, that vascular adaptations are mediated primarily by the more fragile, actively remodeling smaller vessels<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>. Potential mechanisms for differences in vascular response include: (1) expansion (dilation) of small vessel diameters above the limits of image resolution in HDT and contraction below these limits in microgravity, (2) other processes of vascular remodeling such as vaso-obliteration (microvascular rarefaction), or (3) a combination of both. Given the high metabolic cost of vessel loss, neovascularization and angiogenesis, as well as the healthy status of the subjects, the more likely explanation may be that the vessel diameters simply decreased in microgravity and expanded during HDT. Veins typically are of wider caliber than arteries. Overall, venous densities changed less than arterial densities under both HDT bed rest and ISS mission conditions (Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. At the limits of image resolution, perhaps the smaller arterial diameters resulted in increased detection of change, both positive and negative, compared to venous diameters.</p>
              <p id="Par14">In both the HDT bed rest and ISS crew member populations, the retinal vascular response was variable among subjects as well as among the left and right eyes of a single individual. This result conforms with the incidence of SANS as unilateral, bilateral, and of marked variability among astronauts, when diagnosed by clinically established measures such as optic disc edema, cotton wool spots, globe flattening, and total retinal and choroidal thicknesses<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. The results also conform with current ophthalmic findings in astronauts that manifest as a spectrum of cerebral responses and vision impairment<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. For example, although cerebral venous outflow in the internal jugular vein has been shown to stall and even become retrograde during spaceflight, this result is not uniform for all crew members<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. By OCT, subclinical increase in peripapillary retinal thickness as an indicator of ODE also varied among the HDT subjects of this study<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Nonetheless, significant differences in peripapillary retinal thickness were measured after the 14 and 70-day FARU HDT campaigns, together with increased superior, nasal, and inferior peripapillary retinal thicknesses after the 70-day HDT compared to 14 days of HDT<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
              <p id="Par15">Recently, NASA modified the bed rest analog protocol for supine 6° HDT used for the FARU study that is analyzed here. By the newer protocol, subjects maintain a strict HDT posture to sustain the cephalad pressure gradient (i.e., unlike for FARU, subjects retain 6° HDT even while consuming meals). The OCT analysis of a recent 30-day 6° HDT study at envihab<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> was conducted under the stricter posture control that also included mild hypercapnia (0.5% CO<sub>2</sub> above ambient) to further mimic the ISS environment that contains elevated levels of CO<sub>2</sub>. Increases in ODE indicated by increased peripapillary thickness after HDT were greater than in crew members by OCT measurements aboard the ISS, as were trends for greater increases in total choroidal thickness in crew than HDT. In addition, increases in TRT for the strict hypercapnic HDT were statistically significant, unlike insignificant increases in TRT for the 70-day FARU study. However, increased peripapillary TRT was greater after 70 days when compared to 14 days of HDT bed rest at FARU<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>. We therefore speculate that in comparison to the FARU, more stringent HDT bed rest conditions such as greater posture control, increased time of bed rest, and other environmental factors (e.g., mild hypercapnia) could result in increased edematous changes at the level of the optic nerve head, rather than in a fundamental change (switch) to other (unknown) types of vascular and other physiological response.</p>
              <p id="Par16">As a consequence, we hypothesize that a retrospective study of the new strict HDT vascular images would demonstrate that increases in retinal vascular density exceeded those of the slight trends measured in the previous FARU study, although this currently remains unknown. Greater retinal edema with HDT than for the ISS may be associated with the trend toward increased vascular density reported here. Conversely, lesser retinal edema and greater choroidal edema after microgravity compared to HDT may be associated with the decreased vascular density measured by VESGEN for crew members. In a 21-day horizontal bed rest study without HDT, the diameters of the central retinal arteriolar and venular equivalents, another retinal vascular measure, decreased<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. It is possible that as a terrestrial model of SANS, other postures of bed rest without HDT may be more consistent with our measures of retinal vascular decrease following microgravity, rather than with the trend toward retinal vascular increases from HDT bed rest, although many factors differ between our study and the 21-day study.</p>
              <p id="Par17">These differences in retinal vascular patterning and thickness following HDT and ISS missions may arise from somewhat different etiologic mechanisms that depend directly on the presence or almost complete absence of gravity. Other factors such as posture and the position of the head with respect to a terrestrial gravity vector are further discussed below. Edema is a generalized, nonspecific response to numerous pathologies throughout the body that compresses local tissues, and is present in many ocular disorders ranging from diabetic retinopathy to age-related macular degeneration and tissue injury<sup><xref ref-type="bibr" rid="CR37">37</xref>–<xref ref-type="bibr" rid="CR39">39</xref></sup>. Or the differences in retinal response to HDT and the ISS may perhaps depend on a different degree of exposure to elevated intracranial pressure as discussed elsewhere<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. The variability in retinal vascular patterning and thickness measured by the two supine HDT studies discussed above<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup> suggests associations with other physiological factors such as body weight<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>, systemic cardiovascular status<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, and perhaps genetics. Nutrition continues to be studied as potentially important for SANS in microgravity<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> but has been standardized in these HDT studies.</p>
              <p id="Par18">While conditions for the ISS and HDT studies such as use of 30° Spectralis IR imaging reported here were comparable in many important ways, major differences include the length of exposure to the experimental environment (i.e., 70 days of HDT compared to six months on the ISS). The primary limitation of this proof-of-concept study is the low sample size, 16 astronaut retinas (8 subjects) and especially, 10 HDT retinas (5 subjects). Confidence in the results of decreased vessel density in astronauts was high due to low variability of the measured effect<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, but low for increased vessel density with HDT because sampling was limited compared to variability in the effect. Further investigations are required to resolve more conclusively the apparent differences of retinal vascular response that would include larger cohorts, additional time points to define differences between six months on the ISS and the shorter durations of HDT and potentially, the more recent terrestrial spaceflight analog protocol in which the head and body are maintained in stricter HDT<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. In addition, more comprehensive and conclusive associations between retinal vascular responses to HDT and the ISS and major ocular measures such as ODE, TRT, total choroidal thickness, globe flattening, visual acuity, and IOP would be important for such expanded studies that would test the accuracy of this proof-of-concept investigation.</p>
              <p id="Par19">Possible and nonexclusive pathophysiological mechanisms for decreased vessel diameter in microgravity include systemic losses in blood volume<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup> of approximately 10%, vascular compression due to optic disc/peripapillary swelling, and vessel obscuration resulting from subclinical edemas accompanied by tissue compression of the various ocular compartments. Venous pooling in the cephalad region, recently demonstrated for the internal jugular vein, may contribute to SANS and loss of blood volume in retinal vessels<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Conversely, the presence of constant gravity vector during 6° HDT may tend to pool both intravascular and extravascular fluids within the retina and ocular compartments, resulting in vessel dilation. New studies with higher resolution vascular ophthalmic imaging such as optical coherence tomography angiography (OCT-A) would resolve the questions raised by this study on differences of retinal vascular adaptations to microgravity and the HDT flight analog, although OCT-A is currently difficult to use on the ISS.</p>
              <p id="Par20">A further perspective is that the HDT findings suggestive of increased vascular density may indicate an initial response to the cephalad fluid shift on the ISS that during prolonged missions (i.e., greater than 70 days) accompanied by more strict exposure to microgravity may lead to a subsequent decrease in vascular density. As discussed above, further studies are needed not only to resolve these questions on the progression of SANS in microgravity, but also to determine whether vascular parameters at baseline, or a stress test such as a brief exposure to a greater degree of head tilt, can identify subjects at risk of developing SANS.</p>
              <p id="Par21">Overall, postural changes such as HDT and bed rest as spaceflight analogs have helped to advance our understanding of SANS. Both the similarities of ocular response such as optic disc edema and choroidal folds to the fluid shifts in postural changes and microgravity, as well as differences in choroidal and retinal thicknesses<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup> and in vascular patterning as reported for this study, are leading to a better understanding of the complex SANS etiology. However, the opposite vascular response in retinas to HDT and the ISS suggests that the presence and essentially complete absence of gravity in these two environments are of fundamental importance in determining the multiple physiological responses that are both similar and different. Nonetheless, the significance of the terrestrial gravity vector in HDT as a major factor cannot be so easily generalized. As a space flight analog, postural position and the angle of change from horizontal are major factors that modulate fluid shifts and physiological responses within the eye. On Earth, both supine and prone postures increase IOP compared to the upright and seated postures. For this first limited proof-of-concept study, the seated posture during pre- and post-HDT was chosen as most comparable to the seated postures of pre- and post-flight eye exams of astronauts. For the 70-day HDT study reported here, IOP increased by 1.79 mm Hg<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. As reported and discussed in other studies, the downward-tilted prone position (HUT) may perhaps better mimic the ocular and associated cardiovascular changes during long-duration ISS missions than the supine (HDT) position<sup><xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR48">48</xref></sup>. Although changes in IOP during space flight appear variable and without overall increases in IOP 30 days prior to and 30 days after return from flight<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, these previous results may be prone to measurement error. By a recent report, IOP normalizes to preflight values after 4 days of spaceflight<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, and increased IOP has not been shown to be strongly associated with SANS. However, there is renewed interest in examining the role of IOP in space flight<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. In a report of a mathematical model on the influence of supine posture and degree of HDT on IOP compared to horizontal posture, extension of the results on hydrostatic pressure and an autoregulatory component to the prone posture is discussed and commented that modeling the physiology of supine posture is more difficult<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup>.</p>
              <p id="Par22">The VESGEN analysis, together with the SVPI, could be used to monitor and predict risks in crew vision and retinal vascular health for SANS during long duration missions, particularly for detection of early-stage ocular changes that are reversible by future countermeasures. The VESGEN v1.11 software freely and globally released by NASA in 2021<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> contains a new segmentation option that automatically extracts binary vascular patterns by artificial intelligence (AI)/machine learning algorithms for faster, potentially more accurate vascular mapping and quantification. Nonetheless, larger studies beyond this proof-of-concept investigation are required to both confirm the results reported here and expand our understanding of the role of retinal vascular response to long-duration microgravity.</p>
            </sec>
            <sec id="Sec8">
              <title>Methods</title>
              <sec id="Sec9">
                <title>Participants</title>
                <p id="Par23">The HDT and ISS studies adhered to the tenets of the Declaration of Helsinki and following informed consent by participants, were approved by the Institutional Review Boards of The University of Texas Medical Branch, Galveston, Texas<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>, the NASA Johnson Space Center, Houston, Texas, and the NASA Lifetime Surveillance of Astronaut Health (LSAH)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The 70-day HDT study (FARU) of healthy human subjects has been reported extensively elsewhere<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. In brief, five healthy males and one female participated, and the average age was 39.5 ± 7.8 years. The cohort of eight healthy ISS crew members (16 retinas), for which the astronauts were recruited based on study data requirements for pre and post-flight OCT data, was described previously (7 males, 1 female; average age, 46.9 ± 5.4 years)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Because there were no existing data on VESGEN measures of the eye surrounding HDT or spaceflight exposures, statistical power could not be estimated. Sample size was in part limited by costs and schedule. The primary aim of the study emphasized measuring and reporting pre to post-exposure changes over detecting statistically significant changes. The sample size of the HDT cohort (10 retinas, 5 subjects) was increased for the ISS cohort size of 16 retinas (8 crew members) to improve statistical precision for this group.</p>
              </sec>
              <sec id="Sec10">
                <title>Study design</title>
                <p id="Par24">As a comparison of previous HDT and ISS campaigns, the retrospective study was conducted in two phases. In the first phase of blinded vascular analysis, the HDT and ISS databases were established with de-identified retinal images that were masked as to pre-post status (i.e., databases were masked and randomized to remove subject identifiers and temporal sequence of acquisition). The ISS database comprised images of 16 retinas of eight crew members acquired shortly before and after six-month ISS missions (average mission time ± SD, 171 ± 17 days)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The HDT database contained vascular images of the 12 retinas of six human subjects acquired approximately 12 days before and 2 days after 70 days of bed rest at 6° HDT. The retinas of one subject were omitted because the images were unanalyzable due to image blurring. The HDT sample was therefore limited to 10 eyes (5 subjects). Images were then analyzed with VESGEN as described below.</p>
                <p id="Par25">In the second phase, the vascular images and VESGEN results were unblinded and linked to (masked) subject identity and pre-post status. By statistical methods described below, vascular results were evaluated and compared to other ocular outcomes such as retinal thickness, IOP, and visual acuity.</p>
              </sec>
              <sec id="Sec11">
                <title>Imaging</title>
                <p id="Par26">Retinal images of the HDT and ISS cohorts were acquired by Spectralis<sup>®</sup> infrared (IR) 30° imaging (Heidelberg Engineering GmbH, Heidelberg, Germany) as part of two separate research campaigns. Imaging conditions for the two studies were highly similar but differ in some respects. Details of the HDT and ISS imaging are compared in Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>, illustrated in Figs. <xref rid="Fig2" ref-type="fig">2</xref>–<xref rid="Fig4" ref-type="fig">4</xref>, and described previously for both the ISS<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> and HDT<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> cohorts. For example, the Spectralis IR images were focused on the macular region in the HDT cohort and on the optic disc in the ISS cohort, as noted in Results. For accurate comparison of pre–post vascular differences, the Spectralis OCT AutoRescan™ feature was used in each cohort for the acquisition of follow-up images from the same retinal area as at baseline.</p>
              </sec>
              <sec id="Sec12">
                <title>Vascular analysis</title>
                <p id="Par27">The images were analyzed by trained vascular analysts in NASA’s VESGEN Laboratory according to the masked protocol described above. The binary vascular pattern of overlapping arterial and venous trees was first extracted from grayscale IR images by semi-automatic computer processing with Photoshop<sup>®</sup> (Adobe, Mountain View, CA) using large, high-resolution Apple<sup>®</sup> monitors (Cupertino, CA) as reported previously<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. The extracted binary vascular pattern was separated into images of arterial and venous trees by comparison with color fundus photographs (when available) and by basic physiological principles of vascular tree connectivity, branching, vessel tapering, and arterio-venous pairing. Vessel interpretation was subject to agreement by at least two experienced vascular image analysts (with reviews and final decision by a senior analyst). The generational assignment of vessels into large (<italic>G</italic><sub>1-4</sub>) and small (<italic>G</italic><sub>≥5</sub>) groups was determined after early review of the arterio-venous maps and the associated quantified results for four or five retinas. Inspection of the vascular maps such as in Fig. <xref rid="Fig2" ref-type="fig">2</xref> revealed that although subject to biological heterogeneity, the larger generations (<italic>G</italic><sub>1-4</sub>) were generally characterized by relatively symmetric bifurcations that establish the basic arterial and venous arcades. As noted many times previously however, such as in a new review of VESGEN applications<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, the most frequent branching events completing the retinal vascular arborizations are the offshoots of many smaller vessels from much larger vessels, although these numbers of offshoots are relatively limited in the low-resolution Spectralis IR vascular images. This generational group of smaller vessels, as measured for the study reported here, generally appears to remodel most actively<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>.</p>
                <p id="Par28">This is the first application of the VESGEN analysis to a longitudinal study of human retinal images acquired before and after defined time intervals (70 days and six months). For previous<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and concluding cross-sectional studies of diabetic retinopathy, only single images of patients were analyzed. Therefore a new method was developed for this study during the initial blinded vascular analysis phase for straightforward reconciliation of the pre/post binary vascular patterns and of the separated arterial and venous trees. The procedure was initiated to ensure that any differences detected by the vascular analysis could be attributed primarily to differences of vascular response to HDT and microgravity, and not to artifacts of the binary extraction and arterio-venous separation. In addition, although the quality of the pre/post images appeared highly uniform, minor differences in image detection of smaller vessels were expected to result from inevitable limitations such as contrast variation within the images. First, the retinal images were matched as pairs since each human retina displays a unique, individual branching pattern that is easily identifiable by visual inspection (Figs. <xref rid="Fig2" ref-type="fig">2</xref>–<xref rid="Fig4" ref-type="fig">4</xref>). After the vascular binarizations were complete, the two binary images were compared to each other and to the grayscale images to resolve differences resulting from vessel interpretation, which were minor (estimated error, &lt;5%)<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. Remaining vessel differences were retained according to differences observed in the two grayscale images. Overall, the pre/post vascular patterns appeared highly similar by visual inspection for these healthy HDT and astronaut populations. Similarly, interpretations of the separated arterial and venous trees were compared and any differences, again minor, were resolved by inspection of the two grayscale images prior to unmasking of the pre/post status of the grayscale images.</p>
                <p id="Par29">Each binary arterial or venous image, together with the image calibration factor (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>), served as the single input image for the automated mapping and quantification by VESGEN v1.05-1.10 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), written as a complex plug-in to ImageJ (U.S. National Institutes of Health)<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> and now publicly available with user guide upon request to NASA<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Output includes arterial and venous maps, fractal dimension (<italic>D</italic><sub>f</sub>), vessel tortuosity (<italic>T</italic><sub>v</sub>), vessel diameter (<italic>D</italic><sub>v</sub>), and densities of vessel number (<italic>N</italic><sub>v</sub>), length (<italic>L</italic><sub>v</sub>), area (<italic>A</italic><sub>v</sub>) and branch point (<italic>Br</italic><sub>v</sub>) for branching generations <italic>G</italic><sub>1</sub>, <italic>G</italic><sub>2</sub>,…<italic>G</italic><sub>x</sub><sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. The branching generations (<italic>G</italic><sub>1</sub>–<italic>G</italic><sub>x</sub>) are determined by relative decreases in vessel diameter and other considerations of vessel branching and tapering, based on the mechanics of laminar blood flow and also on experimental results for lung and heart vascular branching<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR56">56</xref></sup>. As examples, <italic>L</italic><sub>v1-4</sub> specifies <italic>L</italic><sub>v</sub> with respect to branching generations <italic>G</italic><sub>1</sub>–<italic>G</italic><sub>4</sub> (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) and physical dimensions such as <italic>L</italic><sub>v</sub> = 0.000775 μm/μm<sup>2</sup> are notated as 7.75 × 10<sup>–4</sup> μm/μm<sup>2</sup>.</p>
              </sec>
              <sec id="Sec13">
                <title>Statistics</title>
                <p id="Par30">Analyses were conducted using linear mixed-effects models that included subject-specific random effects (intercept and OD/OS) to account for repeated measures of the left (OS) and right (OD) eyes within individuals and across time. Primary VESGEN measures included <italic>D</italic><sub>f</sub>, <italic>L</italic><sub>v</sub>, <italic>L</italic><sub>v1-4</sub>, and <italic>L</italic><sub>v≥5</sub> for each vascular tree (arteries or veins), and each measure was modeled independently. Robust sandwich standard errors (heteroskedastic-consistent) were used to account for the heterogeneity of variance between groups and across time. Categorical fixed effects were included for time (pre or post) and group (HDT or crew) as an interaction allowing for differential response between groups. An overall F-test determined significance for at least one time and group combination being different from the others. Pairwise comparisons were conducted when the overall F-test was statistically significant. Specifically, pairwise comparisons were conducted on within-group pre to post change (post - pre), as well as the contrast of those changes between groups. Testing for these comparisons was conducted via <italic>t</italic>-tests on the expected marginal means. Analysis of pre- to post-HDT change in subjects is reported in Table <xref rid="Tab2" ref-type="table">2</xref>, and contrasted to space-flight related change in crew in Table <xref rid="Tab1" ref-type="table">1</xref>.</p>
                <p id="Par31">Similarly, mixed models were used to assess the association of VESGEN measures and ocular parameters (RNFL thickness, peripapillary retinal thickness, macular retinal thickness, IOP, spherical equivalent refraction, and near and distance visual acuity logMAR) in the HDT subjects. For this analysis, the models included fixed effects for time and each ocular measure as a covariate (in separate models). Coefficients, standard errors, <italic>p</italic>-values, and corresponding false discovery rates are reported in Table <xref rid="Tab3" ref-type="table">3</xref>.</p>
                <p id="Par32">Models were fit using the GLIMMIX procedure in SAS v9.4. The LSMEANS and LSMESTIMATE statements were used to estimate marginal means and conduct pairwise comparisons (pre to post change within each group, and contrasting those changes between groups). Estimates of the expected marginal means for each time and group combination and comparison included the means, standard errors, confidence limits, and <italic>p</italic>-values.</p>
                <p id="Par33">Residual plots were visually inspected to ensure appropriate conformity to normality assumptions. The VESGEN measures did not deviate from normality and no transformation was necessary. Due to sample size limitations, no adjustments were made to account for multiple testing across the VESGEN measures. The number of tests conducted compared to the limited samples limits interpretation to hypothesis generating, i.e., determining potential areas for confirmatory study.</p>
              </sec>
              <sec id="Sec14">
                <title>Software availability</title>
                <p id="Par34">The VESGEN software with extensive User Guide is publicly available upon request to NASA (<ext-link ext-link-type="uri" xlink:href="https://software.nasa.gov/software/ARC-17621-1">https://software.nasa.gov/software/ARC-17621-1</ext-link>).</p>
              </sec>
              <sec id="Sec15">
                <title>Reporting summary</title>
                <p id="Par35">Further information on research design is available in the <xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec16">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41526_2021_165_MOESM1_ESM.pdf">
                      <caption>
                        <p>Supplementary Information</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="41526_2021_165_MOESM2_ESM.pdf">
                      <caption>
                        <p>Reporting Summary</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p>The online version contains supplementary material available at 10.1038/s41526-021-00165-5.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>The research was supported by Grant NNJ12ZSA002N from the Human Health and Countermeasures, Human Research Program (HRP), U. S. National Aeronautics and Space Administration (NASA) to PPW, GV, GT, MY, and SZ. Additional support to PPW was provided by NASA’s HRP and Space Radiation Programs, Vascular Centennial Challenge, Game-Changing Development, and Ames Center Innovation Fund. The authors gratefully acknowledge Rob Ploutz-Snyder (RPS below), University of Michigan, for the original power design of the study. We thank Terry Condrich and Lorie Passe, NASA Publications (LTID) for original art work (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) and layout editing, respectively.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>All authors discussed results, reviewed the paper, and consented to publication. P.P.W., G.T., G.V., R.P.S., S.B.Z., S.S.M., and M.Y. developed the study concept and plan. G.T. and G.V. provided de-identified HDT ocular data, and S.S.M., de-identified astronaut ocular data. M.Y. performed the biostatistical analysis and developed the statistical models. The VESGEN vascular analysis was led and reviewed by P.P.W., R.J.V., and M.C.M., and expertly performed by R.J.V., M.C.M., S.L., M.P., N.M.J., and K.N.A. The paper was written by P.P.W. with expert contributions by G.T., M.Y., S.L., S.S.M., S.B.Z., G.V., and C.A.T.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>VESGEN vascular results along with associated clinical parameters for the FARU HDT and ISS crew member populations are available in NASA’s Life Sciences Data Archive (LSDA <ext-link ext-link-type="uri" xlink:href="https://lsda.jsc.nasa.gov/Request/dataRequestFAQ">https://lsda.jsc.nasa.gov/Request/dataRequestFAQ</ext-link>) upon request.</p>
            </notes>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par36">The authors declare no competing interests.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mader</surname>
                      <given-names>TH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration space flight</article-title>
                  <source>Ophthalmology</source>
                  <year>2011</year>
                  <volume>118</volume>
                  <fpage>2058</fpage>
                  <lpage>2069</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ophtha.2011.06.021</pub-id>
                  <?supplied-pmid 21849212?>
                  <pub-id pub-id-type="pmid">21849212</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <mixed-citation publication-type="other">Lee, S. M. C., Stenger, M. B., Laurie, S. S. &amp; Macias, B. R. Evidence report: risk of spaceflight-associated neuroocular disorder (SANS). <ext-link ext-link-type="uri" xlink:href="https://humanresearchroadmap.nasa.gov/evidence/reports/SANS.pdf">https://humanresearchroadmap.nasa.gov/evidence/reports/SANS.pdf</ext-link> (U.S. National Aeronautics and Space Administration, 2017, last accessed March 15, 2020).</mixed-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patel</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Pass</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mason</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gibson</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Otto</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Optical coherence tomography analysis of the optic nerve head and surrounding structures in long-duration international space station astronauts</article-title>
                  <source>JAMA Ophthalmol.</source>
                  <year>2018</year>
                  <volume>136</volume>
                  <fpage>193</fpage>
                  <lpage>200</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2017.6226</pub-id>
                  <?supplied-pmid 29327060?>
                  <pub-id pub-id-type="pmid">29327060</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>LF</given-names>
                    </name>
                    <name>
                      <surname>Hargens</surname>
                      <given-names>AR</given-names>
                    </name>
                  </person-group>
                  <article-title>Spaceflight-induced intracranial hypertension and visual impairment: pathophysiology and countermeasures</article-title>
                  <source>Physiol. Rev.</source>
                  <year>2018</year>
                  <volume>98</volume>
                  <fpage>59</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.1152/physrev.00017.2016</pub-id>
                  <?supplied-pmid 29167331?>
                  <pub-id pub-id-type="pmid">29167331</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Laurie</surname>
                      <given-names>SS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Optic disc edema and choroidal engorgement in astronauts during spaceflight and individuals exposed to bed rest</article-title>
                  <source>JAMA Ophthalmol.</source>
                  <year>2020</year>
                  <volume>138</volume>
                  <issue>2</issue>
                  <fpage>165</fpage>
                  <lpage>172</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2019.5261</pub-id>
                  <?supplied-pmid 31876939?>
                  <pub-id pub-id-type="pmid">31876939</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marshall-Goebel</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Damani</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bershad</surname>
                      <given-names>EM</given-names>
                    </name>
                  </person-group>
                  <article-title>Brain physiological response and adaptation during spaceflight</article-title>
                  <source>Neurosurgery</source>
                  <year>2019</year>
                  <volume>85</volume>
                  <fpage>E815</fpage>
                  <lpage>E821</lpage>
                  <pub-id pub-id-type="doi">10.1093/neuros/nyz203</pub-id>
                  <?supplied-pmid 31215633?>
                  <pub-id pub-id-type="pmid">31215633</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marshall-Goebel</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Assessment of jugular venous blood flow stasis and thrombosis during spaceflight</article-title>
                  <source>JAMA Netw. Open</source>
                  <year>2019</year>
                  <volume>2</volume>
                  <fpage>e1915011</fpage>
                  <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.15011</pub-id>
                  <?supplied-pmid 31722025?>
                  <pub-id pub-id-type="pmid">31722025</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kramer</surname>
                      <given-names>LA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Intracranial effects of microgravity: a prospective longitudinal MRI study</article-title>
                  <source>Radiology</source>
                  <year>2020</year>
                  <volume>295</volume>
                  <fpage>640</fpage>
                  <lpage>648</lpage>
                  <pub-id pub-id-type="doi">10.1148/radiol.2020191413</pub-id>
                  <?supplied-pmid 32286194?>
                  <pub-id pub-id-type="pmid">32286194</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>AG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2020</year>
                  <volume>6</volume>
                  <fpage>7</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41526-020-0097-9</pub-id>
                  <?supplied-pmid 32047839?>
                  <pub-id pub-id-type="pmid">32047839</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection</article-title>
                  <source>Microvasc. Res.</source>
                  <year>1998</year>
                  <volume>55</volume>
                  <fpage>201</fpage>
                  <lpage>214</lpage>
                  <pub-id pub-id-type="doi">10.1006/mvre.1998.2073</pub-id>
                  <?supplied-pmid 9657920?>
                  <pub-id pub-id-type="pmid">9657920</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels</article-title>
                  <source>Microvasc. Res.</source>
                  <year>2000</year>
                  <volume>59</volume>
                  <fpage>221</fpage>
                  <lpage>232</lpage>
                  <pub-id pub-id-type="doi">10.1006/mvre.1999.2213</pub-id>
                  <?supplied-pmid 10684728?>
                  <pub-id pub-id-type="pmid">10684728</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Elliott</surname>
                      <given-names>KE</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>JI</given-names>
                    </name>
                    <name>
                      <surname>Farr</surname>
                      <given-names>AG</given-names>
                    </name>
                  </person-group>
                  <article-title>Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree</article-title>
                  <source>Arterioscler. Thromb. Vasc. Biol.</source>
                  <year>2000</year>
                  <volume>20</volume>
                  <fpage>1250</fpage>
                  <lpage>1256</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.ATV.20.5.1250</pub-id>
                  <?supplied-pmid 10807740?>
                  <pub-id pub-id-type="pmid">10807740</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors</article-title>
                  <source>Am. J. Pathol.</source>
                  <year>2005</year>
                  <volume>167</volume>
                  <fpage>193</fpage>
                  <lpage>211</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0002-9440(10)62965-3</pub-id>
                  <?supplied-pmid 15972964?>
                  <pub-id pub-id-type="pmid">15972964</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity</article-title>
                  <source>Microvasc. Res.</source>
                  <year>2006</year>
                  <volume>72</volume>
                  <fpage>91</fpage>
                  <lpage>100</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mvr.2006.05.008</pub-id>
                  <?supplied-pmid 16872639?>
                  <pub-id pub-id-type="pmid">16872639</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting</article-title>
                  <source>Anat. Rec.</source>
                  <year>2006</year>
                  <volume>288</volume>
                  <fpage>233</fpage>
                  <lpage>247</lpage>
                  <pub-id pub-id-type="doi">10.1002/ar.a.20309</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McKay</surname>
                      <given-names>TL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide</article-title>
                  <source>Investig. Ophthalmol. Vis. Sci.</source>
                  <year>2008</year>
                  <volume>49</volume>
                  <fpage>1184</fpage>
                  <lpage>1190</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.07-1329</pub-id>
                  <pub-id pub-id-type="pmid">18326748</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart</article-title>
                  <source>Dev. Dyn.</source>
                  <year>2009</year>
                  <volume>238</volume>
                  <fpage>2760</fpage>
                  <lpage>2769</lpage>
                  <pub-id pub-id-type="doi">10.1002/dvdy.22103</pub-id>
                  <?supplied-pmid 19842184?>
                  <pub-id pub-id-type="pmid">19842184</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vickerman</surname>
                      <given-names>MB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks</article-title>
                  <source>Anat. Rec.</source>
                  <year>2009</year>
                  <volume>292</volume>
                  <fpage>320</fpage>
                  <lpage>332</lpage>
                  <pub-id pub-id-type="doi">10.1002/ar.20862</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Radhakrishnan</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Vickerman</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Kaiser</surname>
                      <given-names>PK</given-names>
                    </name>
                  </person-group>
                  <article-title>Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration analysis (VESGEN)</article-title>
                  <source>Investig. Ophthalmol. Vis. Sci.</source>
                  <year>2010</year>
                  <volume>51</volume>
                  <fpage>498</fpage>
                  <lpage>507</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.09-3968</pub-id>
                  <pub-id pub-id-type="pmid">19797226</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Reinecker</surname>
                      <given-names>HC</given-names>
                    </name>
                  </person-group>
                  <article-title>For application to human spaceflight and ISS experiments: VESGEN mapping of microvascular network remodeling during intestinal inflammation</article-title>
                  <source>Grav. Space Biol.</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <fpage>2</fpage>
                  <lpage>12</lpage>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>X</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation</article-title>
                  <source>PloS ONE</source>
                  <year>2013</year>
                  <volume>8</volume>
                  <fpage>e64227</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0064227</pub-id>
                  <?supplied-pmid 23675530?>
                  <pub-id pub-id-type="pmid">23675530</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zamanian-Daryoush</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2013</year>
                  <volume>288</volume>
                  <fpage>21237</fpage>
                  <lpage>21252</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M113.468967</pub-id>
                  <?supplied-pmid 23720750?>
                  <pub-id pub-id-type="pmid">23720750</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <mixed-citation publication-type="other">Parsons-Wingerter, P. &amp; Vickerman, M. B. Bioinformatic analysis of vascular patterning. U.S. Patent 10,282,841, 2019.</mixed-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <mixed-citation publication-type="other">Lagatuz, M., et al. Vascular patterning as integrative readout of molecular and physiological signaling by downloadable VESGEN analysis. <italic>J. Vasc. Res.</italic>10.1159/000514211 (2021)</mixed-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vyas</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Decreased retinal vascular patterning in ISS crew members as new measure and of ocular damage in SANS</article-title>
                  <source>Investig. Ophthalmol. Vis. Sci.</source>
                  <year>2020</year>
                  <volume>61</volume>
                  <issue>14</issue>
                  <fpage>34</fpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.61.14.34</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <mixed-citation publication-type="other">Hall, J. E. <italic>Guyton and Hall Textbook of Medical Physiology</italic>, The Circulation Chaps. 14–20 (Elsevier Philadelphia PA, 2016).</mixed-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taibbi</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ocular outcomes comparison between 14- and 70-day head-down-tilt bed rest</article-title>
                  <source>Investig. Ophthalmol. Vis. Sci.</source>
                  <year>2016</year>
                  <volume>57</volume>
                  <fpage>495</fpage>
                  <lpage>501</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.15-18530</pub-id>
                  <pub-id pub-id-type="pmid">26868753</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taibbi</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ophthalmological evaluation of integrated resistance and aerobic training during 70-day bed rest</article-title>
                  <source>Aerosp. Med. Hum. Perform.</source>
                  <year>2017</year>
                  <volume>88</volume>
                  <fpage>633</fpage>
                  <lpage>640</lpage>
                  <pub-id pub-id-type="doi">10.3357/AMHP.4768.2017</pub-id>
                  <?supplied-pmid 28641680?>
                  <pub-id pub-id-type="pmid">28641680</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://software.nasa.gov/software/ARC-17621-1">https://software.nasa.gov/software/ARC-17621-1</ext-link>. Vessel Generation Analysis (VESGEN) 2D Software. (U.S. National Aeronautics and Space Administration).</mixed-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Avakian</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fractal analysis of region-based vascular change in the normal and non-proliferative diabetic retina</article-title>
                  <source>Curr. Eye Res.</source>
                  <year>2002</year>
                  <volume>24</volume>
                  <fpage>274</fpage>
                  <lpage>280</lpage>
                  <pub-id pub-id-type="doi">10.1076/ceyr.24.4.274.8411</pub-id>
                  <?supplied-pmid 12324866?>
                  <pub-id pub-id-type="pmid">12324866</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <mixed-citation publication-type="other">Mandelbrot, B. B. <italic>The Fractal Geometry of Nature</italic> (W. H. Freeman, 1983).</mixed-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <mixed-citation publication-type="other">Bassingthwaighte, J. B., Liebovitch, L. S. &amp; West, B. J. <italic>Fractal Physiology</italic> (Oxford Univ. Press, 1994).</mixed-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Vickerman</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <article-title>Informative mapping by VESGEN analysis of venation branching pattern in plant leaves such as <italic>Arabidopsis thaliana</italic>.</article-title>
                  <source>Gravit. Space Res.</source>
                  <year>2011</year>
                  <volume>25</volume>
                  <fpage>69</fpage>
                  <lpage>71</lpage>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parsons-Wingerter</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hosamani</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Vickerman</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Bhattacharya</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Mapping by VESGEN of wing vein phenotype in Drosophila for quantifying adaptations to space</article-title>
                  <source>Environ. Grav. Space Res.</source>
                  <year>2015</year>
                  <volume>3</volume>
                  <fpage>54</fpage>
                  <lpage>64</lpage>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Supuran</surname>
                      <given-names>CT</given-names>
                    </name>
                  </person-group>
                  <article-title>Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review</article-title>
                  <source>Expert Opin. Ther. Pat.</source>
                  <year>2019</year>
                  <volume>29</volume>
                  <fpage>761</fpage>
                  <lpage>767</lpage>
                  <pub-id pub-id-type="doi">10.1080/13543776.2019.1671353</pub-id>
                  <?supplied-pmid 31540558?>
                  <pub-id pub-id-type="pmid">31540558</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Louwies</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Separate and combined effects of hypoxia and horizontal bed rest on retinal blood vessel diameters</article-title>
                  <source>Investig. Ophthalmol. Vis. Sci.</source>
                  <year>2016</year>
                  <volume>57</volume>
                  <fpage>4927</fpage>
                  <lpage>4932</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.16-19968</pub-id>
                  <pub-id pub-id-type="pmid">27654419</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McQueen</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Christie</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Court-Brown</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>Acute compartment syndrome in tibial diaphyseal fractures</article-title>
                  <source>J. Bone Jt. Surg. Br.</source>
                  <year>1996</year>
                  <volume>78</volume>
                  <fpage>95</fpage>
                  <lpage>98</lpage>
                  <pub-id pub-id-type="doi">10.1302/0301-620X.78B1.0780095</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Balogh</surname>
                      <given-names>Z</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Abdominal compartment syndrome: the cause or effect of postinjury multiple organ failure</article-title>
                  <source>Shock</source>
                  <year>2003</year>
                  <volume>20</volume>
                  <fpage>483</fpage>
                  <lpage>492</lpage>
                  <pub-id pub-id-type="doi">10.1097/01.shk.0000093346.68755.43</pub-id>
                  <?supplied-pmid 14625470?>
                  <pub-id pub-id-type="pmid">14625470</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schubert</surname>
                      <given-names>AG</given-names>
                    </name>
                  </person-group>
                  <article-title>Exertional compartment syndrome: review of the literature and proposed rehabilitation guidelines following surgical release</article-title>
                  <source>Int. J. Sports Phys. Ther.</source>
                  <year>2011</year>
                  <volume>6</volume>
                  <fpage>126</fpage>
                  <lpage>141</lpage>
                  <?supplied-pmid 21713230?>
                  <pub-id pub-id-type="pmid">21713230</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buckey</surname>
                      <given-names>JC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Microgravity-induced ocular changes are related to body weight</article-title>
                  <source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source>
                  <year>2018</year>
                  <volume>315</volume>
                  <fpage>R496</fpage>
                  <lpage>R499</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpregu.00086.2018</pub-id>
                  <?supplied-pmid 29768035?>
                  <pub-id pub-id-type="pmid">29768035</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Zwart</surname>
                      <given-names>SR</given-names>
                    </name>
                  </person-group>
                  <article-title>Spaceflight-related ocular changes: the potential role of genetics, and the potential of B vitamins as a countermeasure</article-title>
                  <source>Curr. Opin. Clin. Nutr. Metab. Care</source>
                  <year>2018</year>
                  <volume>21</volume>
                  <fpage>481</fpage>
                  <lpage>488</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCO.0000000000000510</pub-id>
                  <?supplied-pmid 30169456?>
                  <pub-id pub-id-type="pmid">30169456</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://www.nasa.gov/analogs/envihab">https://www.nasa.gov/analogs/envihab</ext-link>. Analog Missions: AGBRESA at Envihab. (U.S. National Aeronautics and Space Administration) Last accessed July 2020.</mixed-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Diedrich</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Paranjape</surname>
                      <given-names>SY</given-names>
                    </name>
                    <name>
                      <surname>Robertson</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Plasma and blood volume in space</article-title>
                  <source>Am. J. Med Sci.</source>
                  <year>2007</year>
                  <volume>334</volume>
                  <fpage>80</fpage>
                  <lpage>85</lpage>
                  <pub-id pub-id-type="doi">10.1097/MAJ.0b013e318065b89b</pub-id>
                  <?supplied-pmid 17630598?>
                  <pub-id pub-id-type="pmid">17630598</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Norsk</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Asmar</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Damgaard</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Christensen</surname>
                      <given-names>NJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Fluid shifts, vasodilatation and ambulatory blood pressure reduction during long duration spaceflight</article-title>
                  <source>J. Physiol.</source>
                  <year>2015</year>
                  <volume>593</volume>
                  <fpage>573</fpage>
                  <lpage>584</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.2014.284869</pub-id>
                  <?supplied-pmid 25774397?>
                  <pub-id pub-id-type="pmid">25774397</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anderson</surname>
                      <given-names>AP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acute effects of changes to the gravitational vector on the eye</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2016</year>
                  <volume>120</volume>
                  <fpage>939</fpage>
                  <lpage>946</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00730.2015</pub-id>
                  <?supplied-pmid 26662052?>
                  <pub-id pub-id-type="pmid">26662052</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anderson</surname>
                      <given-names>AP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ocular changes over 60 min in supine and prone postures</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2017</year>
                  <volume>123</volume>
                  <fpage>415</fpage>
                  <lpage>423</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.00687.2016</pub-id>
                  <?supplied-pmid 28546470?>
                  <pub-id pub-id-type="pmid">28546470</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mekjavic</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Amoaku</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Mlinar</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Mekjavic</surname>
                      <given-names>IB</given-names>
                    </name>
                  </person-group>
                  <article-title>The aetiology of spaceflight-associated neuro-ocular syndrome might be explained by a neural mechanism regulating intraocular pressure</article-title>
                  <source>J. Physiol.</source>
                  <year>2020</year>
                  <volume>598</volume>
                  <fpage>1431</fpage>
                  <lpage>1432</lpage>
                  <pub-id pub-id-type="doi">10.1113/JP279699</pub-id>
                  <?supplied-pmid 32118293?>
                  <pub-id pub-id-type="pmid">32118293</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mekjavic</surname>
                      <given-names>IB</given-names>
                    </name>
                    <name>
                      <surname>Amoaku</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Mlinar</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Mekjavic</surname>
                      <given-names>PJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Hypercapnia augments resistive exercise-induced elevations in intraocular pressure in older individuals</article-title>
                  <source>Exp. Physiol.</source>
                  <year>2020</year>
                  <volume>105</volume>
                  <fpage>641</fpage>
                  <lpage>652</lpage>
                  <pub-id pub-id-type="doi">10.1113/EP088236</pub-id>
                  <?supplied-pmid 32034962?>
                  <pub-id pub-id-type="pmid">32034962</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nelson</surname>
                      <given-names>ES</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acute effects of posture on introcular pressure</article-title>
                  <source>PLoS ONE</source>
                  <year>2020</year>
                  <volume>15</volume>
                  <fpage>1</fpage>
                  <lpage>17. e0226915</lpage>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Stenger</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Macias</surname>
                      <given-names>BR</given-names>
                    </name>
                  </person-group>
                  <article-title>Gravitational influence on intraocular pressure: implications for spaceflight and disease</article-title>
                  <source>J. Glaucoma</source>
                  <year>2019</year>
                  <volume>28</volume>
                  <fpage>756</fpage>
                  <lpage>764</lpage>
                  <pub-id pub-id-type="doi">10.1097/IJG.0000000000001293</pub-id>
                  <?supplied-pmid 31162175?>
                  <pub-id pub-id-type="pmid">31162175</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taibbi</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ocular outcomes evaluation in a 14-day head-down bed rest study</article-title>
                  <source>Aviat. Space Environ. Med.</source>
                  <year>2014</year>
                  <volume>85</volume>
                  <fpage>983</fpage>
                  <lpage>992</lpage>
                  <pub-id pub-id-type="doi">10.3357/ASEM.4055.2014</pub-id>
                  <?supplied-pmid 25245897?>
                  <pub-id pub-id-type="pmid">25245897</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <mixed-citation publication-type="other">H.E.R.O. in Solicitation 80JSCC019N001, National Aeronautics and Space Administration, 2019.</mixed-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <mixed-citation publication-type="other"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/download.html">https://imagej.nih.gov/ij/download.html</ext-link>. ImageJ. U. S. National Institutes of Health.</mixed-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gan</surname>
                      <given-names>RZ</given-names>
                    </name>
                    <name>
                      <surname>Tian</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Yen</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Kassab</surname>
                      <given-names>GS</given-names>
                    </name>
                  </person-group>
                  <article-title>Morphometry of the dog pulmonary venous tree</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>1993</year>
                  <volume>75</volume>
                  <fpage>432</fpage>
                  <lpage>440</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.1993.75.1.432</pub-id>
                  <?supplied-pmid 8376295?>
                  <pub-id pub-id-type="pmid">8376295</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kassab</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Rider</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Fung</surname>
                      <given-names>YC</given-names>
                    </name>
                  </person-group>
                  <article-title>Morphometry of pig coronary arterial trees</article-title>
                  <source>Am. J. Physio.</source>
                  <year>1993</year>
                  <volume>265</volume>
                  <fpage>H350</fpage>
                  <lpage>H365</lpage>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kassab</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Fung</surname>
                      <given-names>YC</given-names>
                    </name>
                  </person-group>
                  <article-title>Morphometry of pig coronary venous system</article-title>
                  <source>Am. J. Physiol.</source>
                  <year>1994</year>
                  <volume>267</volume>
                  <fpage>H2100</fpage>
                  <lpage>H2113</lpage>
                  <?supplied-pmid 7810711?>
                  <pub-id pub-id-type="pmid">7810711</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schwen</surname>
                      <given-names>LO</given-names>
                    </name>
                    <name>
                      <surname>Preusser</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Analysis and algorithmic generation of hepatic vascular systems</article-title>
                  <source>Int. J. Hepatol.</source>
                  <year>2012</year>
                  <volume>2012</volume>
                  <fpage>357687</fpage>
                  <pub-id pub-id-type="doi">10.1155/2012/357687</pub-id>
                  <?supplied-pmid 23056953?>
                  <pub-id pub-id-type="pmid">23056953</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Costa</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>End-to-end adversarial retinal image synthesis</article-title>
                  <source>IEEE Trans. Med. Imaging</source>
                  <year>2018</year>
                  <volume>37</volume>
                  <fpage>781</fpage>
                  <lpage>791</lpage>
                  <pub-id pub-id-type="doi">10.1109/TMI.2017.2759102</pub-id>
                  <?supplied-pmid 28981409?>
                  <pub-id pub-id-type="pmid">28981409</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
